Abstract
Objective
To experimentally clarify the symptomatological and pathophysiological aspects of a newly proposed clinical entity, we produced an experimental rat “hydrocephalus-parkinsonism complex” model.
Methods
A total of 60 male Sprague-Dawley rats were used. Twenty rats were treated with only kaolin as controls. Hemiparkinsonism was induced in the other 40 rats by stereotactic injection of 6-hydroxydopamine (6-OHDA) directly into the right substantia nigra. Twenty of these 40 rats were then treated with an injection of kaolin into the cisterna magna 3 days after the induction of parkinsonism. Neurological features were assessed weekly for 1 to 6 weeks after 6-OHDA injection by an apomorphine-induced turning test.
Results
The mortality rate was 25% in the rats injected with kaolin and 10% in those with the 6-OHDA injection. The frequency of the induction of parkinsonism-like signs was minimal in the first 2 weeks and reached a maximum point 4 weeks after the 6-OHDA injection. In contrast, the rats injected with both 6-OHDA and kaolin developed hemiparkinsonism-like signs in the early stage of the progression of hydrocephalus, and the peak incidence was reached in the 2nd week after induction (p<0.05 compared with the 6-OHDA group). The severity of the neurological disturbance was also significantly more prominent in the latter group.
Conclusion
These results suggest that the hydrodynamic effect in the early period of ventriculomegaly is the mechanism for signs of parkinsonism in 6-OHDA-treated rats. It could be concluded that the hydrocephalic state aggravates parkinsonism, if any as the associated condition, and it may be a new clinical entity of hydrocephalus symptomatology with a specific pathophysiology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baik JH, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, Le Meur M, Borrelli E (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377:424–428
Bankiewicz KS, Palmatier M, Plunkett RJ, Cummins A, Oldfield EH (1994) Reversal of hemiparkinsonism syndrome in nonhuman primates by amnion implantation into caudate nucleus. J Neurosurg 81:869–876
Barrer SJ, Schut L, Bruce DA (1980) Global rostral midbrain dysfunction secondary to shunt malfunction in hydrocephalus. Neurosurgery 7:322–325
Basso MA, Strecker RE, Evinger C (1993) Midbrain 6-hydroxydopamine lesions modulate blink reflex excitability. Exp Brain Res 94:88–96
Brazin ME, Epstein LG (1985) Reversible parkinsonism from shunt failure. Pediatr Neurol 1:306–307
Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydroridine. Proc Natl Acad Sci USA 80:4546–4550
Gancher S, Crabbe J, Garland A, Lea E, Woodward W (1995) Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of parkinsonism. J Pharmacol Exp Ther 272:275–281
Jankovic J, Newmark M, Peter P (1986) Parkinsonism and acquired hydrocephalus. Mov Disord 1:59–64
Keane JR (1995) Tremor as the result of shunt obstruction: four patients with cysticercosis and secondary parkinsonism: report of four cases. Neurosurgery 37:520–522
Musella R, Elvidge AR (1964) Parkinsonian-like syndrome caused by cyst in posterior fossa: report of a case. J Neurosurg 21:62–65
Oi S, Hidaka M, Matsuzawa K, Tominaga J, Atsumi H, Sato O (1995) Intractable hydrocephalus in a form of progressive and irreversible “hydrocephalus-parkinsonism complex”—a case report. Curr Trends Hydroceph (Tokyo) 5:43–49
Oi S, Hidaka M, Matsuzawa K, Shibata M, Sato O (2003) “Hydrocephalus-parkinsonism complex”: unique symptomatology of progressive hydrocephalus and shunt dependency. Clinical analysis. Neurosurgery (in press)
Reyes JAD (1970) Parkinsonian-like syndrome caused by posterior fossa tumor: case report. J Neurosurg 33:599–601
Richard MG, Bennett Jr JP (1994) Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism. Exp Neurol 129:57–63
Sakai K, Gash DM (1994) Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat. Brain Res 633:144–150
16 Shahar E, Lambert R, Hwang PA, Hoffman HJ (1988) Obstructive hydrocephalus-induced parkinsonism. I. Decreased basal ganglia regional blood flow. Pediatr Neurol 4:117–119
Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69–93
Wang J, Bakniewicz KS, Plunkett RJ, Oldfield EH (1994) Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain. J Neurosurg 80:484–490
Winn SR, Wahlberg L, Tresco PA, Aebischer P (1989) An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Exp Neurol 105:244–250
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s00381-004-0965-8
Rights and permissions
About this article
Cite this article
Oi, S., Kim, D.S. & Hidaka, M. “Hydrocephalus-parkinsonism complex”: progressive hydrocephalus as a factor affecting extrapyramidal tract disorder—an experimental study. Childs Nerv Syst 20, 37–40 (2004). https://doi.org/10.1007/s00381-003-0801-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-003-0801-6